US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sparton

18.51

0.0000

Volume:- -

Turnover:- -

Market Cap:182.04M

PE:46.14

High:18.51

Open:18.51

Low:18.51

Close:18.51

Loading ...

Overview Company News Filings

Strong Buy Recommendation for Arnoldo Mondadori Editore SPA: Robust Financial Performance and Growth Prospects

Barclays Keeps Their Hold Rating on Poste Italiane SPA (0RC2)

Signing Day Sports Executes Stock Purchase Agreement to Acquire Majority of Capital Stock of Dear Cashmere Group Holding Company d/b/a Swifty Global

Kepler Capital Reaffirms Their Buy Rating on Poste Italiane SPA (0RC2)

Banco di Desio e Della Brianza SPA Announces 2025 Corporate Event Calendar

Banca Monte dei Paschi di Siena SPA (0RK6) Receives a Rating Update from a Top Analyst

Kepler Capital Sticks to Its Buy Rating for Interpump Group SPA (0EWD)

Sogefi SPA (0NV0) Gets a Hold from Kepler Capital

Brembo SPA (0RPV) Gets a Hold from Kepler Capital

Outlook Therapeutics Vision Loss Drug At Par With Novartis Drug

Outlook Therapeutics® Announces Complete Twelve Week Efficacy and Safety Results of NORSE EIGHT Clinical Trial

Candel Therapeutics Provides Corporate Update and Highlights Strong Pipeline Momentum and Key Value Drivers for 2025

Leader Environmental Tech enters into conditional agreement to dispose shares in AIWater for $67.9 mil

Brera Holdings Amends SPA with XX Settembre Holding

Spero Therapeutics Provides Business Update and Announces Interim Leadership Changes

Press Release: Global Mofy Announces Fiscal Year 2024 Financial Results; Conference Call Scheduled for Friday, January 3rd, at 9:00 AM Eastern Time

BCLI: Plans Coming Together for Phase 3b Trial of NurOwn® in ALS…

Zacks Small Cap Research

Alibaba Group Holding's Subsidiaries to Dispose Of 78.70% Stake in Sun Art

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/SPA/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SPA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SPA\",,,,,undefined,":{"symbol":"SPA","market":"US","secType":"STK","nameCN":"Sparton","latestPrice":18.51,"timestamp":1575925200000,"preClose":18.51,"halted":4,"volume":0,"delay":0,"floatShares":8332448,"shares":9834723,"eps":0.401149,"marketStatus":"Delisted","change":0,"latestTime":"12-09 16:00:00 EST","open":18.51,"high":18.51,"low":18.51,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.401149,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1747641600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":18.51,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SPA\",,,,,undefined,":{"symbol":"SPA","floatShares":8332448,"roa":"--","roe":"--","lyrEps":-0.839271,"shares":9834723,"dividePrice":0,"high":18.51,"amplitude":0,"preClose":18.51,"low":18.51,"week52Low":11.955,"pbRate":"2.41","week52High":22.89,"institutionHeld":0.623,"latestPrice":18.51,"eps":0.401149,"divideRate":0,"volume":0,"delay":0,"ttmEps":0.401149,"open":18.51},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SPA\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2507610973","title":"Strong Buy Recommendation for Arnoldo Mondadori Editore SPA: Robust Financial Performance and Growth Prospects","url":"https://stock-news.laohu8.com/highlight/detail?id=2507610973","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507610973?lang=en_us&edition=fundamental","pubTime":"2025-01-30 16:55","pubTimestamp":1738227328,"startTime":"0","endTime":"0","summary":"Analyst Andrea Randone from Intermonte maintained a Buy rating on Arnoldo Mondadori Editore SPA (0KAV – Research Report) and decreased the price ta...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/strong-buy-recommendation-for-arnoldo-mondadori-editore-spa-robust-financial-performance-and-growth-prospects?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/strong-buy-recommendation-for-arnoldo-mondadori-editore-spa-robust-financial-performance-and-growth-prospects?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SPA"],"gpt_icon":0},{"id":"2507228616","title":"Barclays Keeps Their Hold Rating on Poste Italiane SPA (0RC2)","url":"https://stock-news.laohu8.com/highlight/detail?id=2507228616","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507228616?lang=en_us&edition=fundamental","pubTime":"2025-01-30 14:36","pubTimestamp":1738218974,"startTime":"0","endTime":"0","summary":"In a report released today, Paola Sabbione from Barclays maintained a Hold rating on Poste Italiane SPA (0RC2 – Research Report), with a price targ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/barclays-keeps-their-hold-rating-on-poste-italiane-spa-0rc2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/barclays-keeps-their-hold-rating-on-poste-italiane-spa-0rc2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SPA","PITAF"],"gpt_icon":0},{"id":"2507636162","title":"Signing Day Sports Executes Stock Purchase Agreement to Acquire Majority of Capital Stock of Dear Cashmere Group Holding Company d/b/a Swifty Global","url":"https://stock-news.laohu8.com/highlight/detail?id=2507636162","media":"GlobeNewswire","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507636162?lang=en_us&edition=fundamental","pubTime":"2025-01-29 22:00","pubTimestamp":1738159200,"startTime":"0","endTime":"0","summary":"Expected acquisition of Swifty Global would contribute strong historical financials and significant growth potential. SCOTTSDALE, Arizona, Jan. 29, 2025  -- Signing Day Sports, Inc.  , the developer of the Signing Day Sports app and platform to aid high school athletes in the recruitment process, today announced the signing of a Stock Purchase Agreement  to acquire 99.13% of the issued and outstanding capital stock of Dear Cashmere Group Holding Company , doing business as Swifty Global.Swifty Global is a global online sports and casino technologies company with a track record of revenue growth and profitability.Swifty Global’s strengths and growth strategies are expected to contribute significantly to the Company’s growth potential, including:. Global Expansion Targeting High Growth Markets: Swifty Global continues to expand its international gambling operations with significant growth opportunities on the horizon. This strategy aligns with the shared vision of both companies to targe","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/signing-day-sports-executes-stock-140000814.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4023","SPA","SGN"],"gpt_icon":0},{"id":"2507571542","title":"Kepler Capital  Reaffirms Their Buy Rating on Poste Italiane SPA (0RC2)","url":"https://stock-news.laohu8.com/highlight/detail?id=2507571542","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507571542?lang=en_us&edition=fundamental","pubTime":"2025-01-29 09:47","pubTimestamp":1738115247,"startTime":"0","endTime":"0","summary":"In a report released on January 27, Tommaso Nieddu from Kepler Capital maintained a Buy rating on Poste Italiane SPA (0RC2 – Research Report), with...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/kepler-capital-reaffirms-their-buy-rating-on-poste-italiane-spa-0rc2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/kepler-capital-reaffirms-their-buy-rating-on-poste-italiane-spa-0rc2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SPA","PITAF"],"gpt_icon":0},{"id":"2507541322","title":"Banco di Desio e Della Brianza SPA Announces 2025 Corporate Event Calendar","url":"https://stock-news.laohu8.com/highlight/detail?id=2507541322","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507541322?lang=en_us&edition=fundamental","pubTime":"2025-01-29 01:28","pubTimestamp":1738085280,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Banco di Desio e Della Brianza SPA ( ($IT:BDB) ). Banco di Desio e Della Brianza SPA has released its calendar ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/banco-di-desio-e-della-brianza-spa-announces-2025-corporate-event-calendar?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/banco-di-desio-e-della-brianza-spa-announces-2025-corporate-event-calendar?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SPA"],"gpt_icon":0},{"id":"2504229814","title":"Banca Monte dei Paschi di Siena SPA (0RK6) Receives a Rating Update from a Top Analyst","url":"https://stock-news.laohu8.com/highlight/detail?id=2504229814","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504229814?lang=en_us&edition=fundamental","pubTime":"2025-01-20 15:36","pubTimestamp":1737358568,"startTime":"0","endTime":"0","summary":"Barclays analyst Paola Sabbione maintained a Buy rating on Banca Monte dei Paschi di Siena SPA (0RK6 – Research Report) today. The company’s shares...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/banca-monte-dei-paschi-di-siena-spa-0rk6-receives-a-rating-update-from-a-top-analyst-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/banca-monte-dei-paschi-di-siena-spa-0rk6-receives-a-rating-update-from-a-top-analyst-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SPA"],"gpt_icon":0},{"id":"2504439843","title":"Kepler Capital  Sticks to Its Buy Rating for Interpump Group SPA (0EWD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2504439843","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504439843?lang=en_us&edition=fundamental","pubTime":"2025-01-19 09:36","pubTimestamp":1737250570,"startTime":"0","endTime":"0","summary":"In a report released on January 17, Matteo Bonizzoni from Kepler Capital maintained a Buy rating on Interpump Group SPA (0EWD – Research Report), w...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/kepler-capital-sticks-to-its-buy-rating-for-interpump-group-spa-0ewd-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/kepler-capital-sticks-to-its-buy-rating-for-interpump-group-spa-0ewd-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SPA"],"gpt_icon":0},{"id":"2504979816","title":"Sogefi SPA (0NV0) Gets a Hold from Kepler Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2504979816","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504979816?lang=en_us&edition=fundamental","pubTime":"2025-01-17 09:36","pubTimestamp":1737077771,"startTime":"0","endTime":"0","summary":"In a report released on January 15, Alexandre Raverdy from Kepler Capital maintained a Hold rating on Sogefi SPA (0NV0 – Research Report), with a p...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/sogefi-spa-0nv0-gets-a-hold-from-kepler-capital?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/sogefi-spa-0nv0-gets-a-hold-from-kepler-capital?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SPA"],"gpt_icon":0},{"id":"2504697982","title":"Brembo SPA (0RPV) Gets a Hold from Kepler Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2504697982","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504697982?lang=en_us&edition=fundamental","pubTime":"2025-01-17 09:36","pubTimestamp":1737077766,"startTime":"0","endTime":"0","summary":"In a report released on January 15, Alexandre Raverdy from Kepler Capital maintained a Hold rating on Brembo SPA (0RPV – Research Report), with a p...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/brembo-spa-0rpv-gets-a-hold-from-kepler-capital-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/brembo-spa-0rpv-gets-a-hold-from-kepler-capital-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SPA"],"gpt_icon":0},{"id":"2504948330","title":"Outlook Therapeutics Vision Loss Drug At Par With Novartis Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2504948330","media":"Benzinga","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504948330?lang=en_us&edition=fundamental","pubTime":"2025-01-17 01:09","pubTimestamp":1737047390,"startTime":"0","endTime":"0","summary":"On Thursday, Outlook Therapeutics, Inc.  completed the analysis of the complete 12-week safety and efficacy results for NORSE EIGHT evaluating ONS-5010 in wet age-related macular degeneration  patients.ONS-5010 demonstrated non-inferiority to Novartis AG  / Roche Holdings AG’s  Lucentis  at week 12 in the NORSE EIGHT trial. Based on the completed analysis of the 12-week results, Outlook Therapeutics plans to resubmit the Biologics License Application  for ONS-5010 in the first quarter of calendar 2025.The difference in the mean between ONS-5010 and ranibizumab was -1.009 best corrected visual acuity  letters.In the intent-to-treat  population, NORSE EIGHT demonstrated a mean 5.5 letter improvement in BCVA in the ONS-5010 arm and 6.5 letter improvement in BCVA in the ranibizumab arm.As previously announced, in the NORSE EIGHT trial, ONS-5010 did not meet the pre-specified non-inferiority endpoint at week 8 outlined in the special protocol assessment  with the U.S. Food and Drug Administ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/outlook-therapeutics-vision-loss-drug-170950455.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B4R5TH58.HKD","BK4585","BK4161","LU0053671581.USD","IE0002141913.USD","OTLK","IE00B2B36J28.USD","IE00BJT1NW94.SGD","SPA","NVS","BK4139","IE0009355771.USD","IE00BJJMRZ35.SGD","BK4588","BK4532","ITT","IE00BFTCPJ56.SGD","BK4007","BK4578","LU0054578231.USD","LENZ","LU0211331839.USD"],"gpt_icon":0},{"id":"2503962817","title":"Outlook Therapeutics® Announces Complete Twelve Week Efficacy and Safety Results of NORSE EIGHT Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2503962817","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503962817?lang=en_us&edition=fundamental","pubTime":"2025-01-16 19:00","pubTimestamp":1737025200,"startTime":"0","endTime":"0","summary":"ONS-5010 demonstrated to be non-inferior to Lucentis at 12 weeks. Entered into agreements for warrant inducement transaction expected to result in up to $20.4 million in gross proceeds. Julia A. Haller, MD, Ophthalmologist-in-Chief at Wills Eye Hospital and an Outlook Therapeutics Board member, commented, “The 3-month data from NORSE EIGHT provides additional evidence to confirm what retina specialists expected. The clinical trial continues to demonstrate that ONS-5010 injections result in immediate and sustained anatomic efficacy, with steady gains in visual acuity and reliable, consistent safety.”As previously announced, in the NORSE EIGHT trial, ONS-5010 did not meet the pre-specified non-inferiority endpoint at week 8 set forth in the special protocol assessment  with the U.S. Food and Drug Administration . However, BCVA data across all study timepoints demonstrated an im","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/outlook-therapeutics-announces-complete-twelve-110000275.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4512","IE00BMPRXN33.USD","LU2098885051.SGD","LU2360106780.USD","LU0390134368.USD","LU0823434740.USD","ITT","LU0082616367.USD","LU0127658192.USD","BK4534","LU0198837287.USD","IE00BMPRXR70.SGD","OTLK","BK4575","LU1880398471.USD","LU1988902786.USD","LU0109392836.USD","LU0642271901.SGD","LU2458330169.SGD","IE00B5949003.HKD","LU0054578231.USD","LU0053671581.USD","BK4543","LU0823421333.USD","LU0719512351.SGD","BK4566","LU1951198990.SGD","LU0889565833.HKD","IE0009356076.USD","LU2054465674.USD","BK4205","LU1923623000.USD","LU0081259029.USD","GFS","LU1951200564.SGD","LU0056508442.USD","LU0823421416.USD","SPA","LU1242518931.SGD","LU1303367103.USD","BK4529","LENZ","LU0979878070.USD","BK4141","LU2250418816.HKD","BK4532","BK4139","UK"],"gpt_icon":1},{"id":"2503099183","title":"Candel Therapeutics Provides Corporate Update and Highlights Strong Pipeline Momentum and Key Value Drivers for 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2503099183","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503099183?lang=en_us&edition=fundamental","pubTime":"2025-01-13 21:00","pubTimestamp":1736773200,"startTime":"0","endTime":"0","summary":"On track to report updated overall survival data for CAN-2409 from phase 2a clinical trials in pancreatic ductal adenocarcinoma  and non-small cell lung cancer , expected in Q1 2025. Preparations for Biologics License Application  for CAN-2409 in prostate cancer underway, with submission expected in Q4 2026. The Company intends to present phase 3 clinical trial data from CAN-2409 in prostate cancer at upcoming scientific conferences. On track to report overall survival data in patients with recurrent high-grade glioma  from ongoing phase 1b trial evaluating multiple doses of CAN-3110, expected in Q4 2025. The Company expects that its cash and cash equivalents of approximately $103M  as of December 31, 2024, will be sufficient to fund its current operating plan into Q1 of 2027. Dr. Tak continued, “We are entering 2025 with clear momentum. Our primary focus will be achieving BLA readiness for CAN-2409 in prostate cancer. If approved, we believe that CAN-2409 has the potential to become a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/candel-therapeutics-provides-corporate-highlights-130000779.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","CADL","BK4166","BK4231","BK4080","LU1791807156.HKD","LU1861217088.USD","LU1861220207.SGD","BK4588","DFS","LENZ","LU2360107671.USD","BK4595","LU0053666078.USD","BK4107","LU1668664300.SGD","SITC","L","TLS","BK4526","LU0106831901.USD","SPA","BK4539","BK4170","BK4097","BK4139","BK4600"],"gpt_icon":1},{"id":"2503304583","title":"Leader Environmental Tech enters into conditional agreement to dispose shares in AIWater for $67.9 mil","url":"https://stock-news.laohu8.com/highlight/detail?id=2503304583","media":"Felicia Tan","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503304583?lang=en_us&edition=fundamental","pubTime":"2025-01-13 02:43","pubTimestamp":1736707417,"startTime":"0","endTime":"0","summary":"As the proposed disposals are regarded as a major transaction, the company will convene an EGM to seek the approval of its independent shareholders.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theedgesingapore.com/news/company-news/leader-environmental-tech-enters-conditional-agreement-dispose-shares-aiwater-679?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"edge_highlight","symbols":["SPA","NAV"],"gpt_icon":0},{"id":"2502846815","title":"Brera Holdings Amends SPA with XX Settembre Holding","url":"https://stock-news.laohu8.com/highlight/detail?id=2502846815","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502846815?lang=en_us&edition=fundamental","pubTime":"2025-01-11 06:50","pubTimestamp":1736549456,"startTime":"0","endTime":"0","summary":"Brera Holdings PLC Class B ( ($BREA) ) has issued an announcement. Brera Holdings PLC has entered into an amended and consolidated Sale and Purchas...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/brera-holdings-amends-spa-with-xx-settembre-holding?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/brera-holdings-amends-spa-with-xx-settembre-holding?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SPA"],"gpt_icon":0},{"id":"2502852817","title":"Spero Therapeutics Provides Business Update and Announces Interim Leadership Changes","url":"https://stock-news.laohu8.com/highlight/detail?id=2502852817","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502852817?lang=en_us&edition=fundamental","pubTime":"2025-01-10 20:00","pubTimestamp":1736510400,"startTime":"0","endTime":"0","summary":"Esther Rajavelu Appointed Interim President and Chief Executive Officer, Frank Thomas Appointed Chairman of the Board Interim Changes to Leadership Follow the Company’s Response to a Wells Notice from","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/01/10/3007532/0/en/Spero-Therapeutics-Provides-Business-Update-and-Announces-Interim-Leadership-Changes.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPA","BK4139","AP","LENZ","BK4006"],"gpt_icon":0},{"id":"2501209217","title":"Press Release: Global Mofy Announces Fiscal Year 2024 Financial Results; Conference Call Scheduled for Friday, January 3rd, at 9:00 AM Eastern Time","url":"https://stock-news.laohu8.com/highlight/detail?id=2501209217","media":"Dow Jones","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501209217?lang=en_us&edition=fundamental","pubTime":"2025-01-07 21:30","pubTimestamp":1736256600,"startTime":"0","endTime":"0","summary":"Global Mofy Announces Fiscal Year 2024 Financial Results; Conference Call Scheduled for Friday, January 3rd, at 9:00 AM Eastern Time. - Total Revenue of $41.4 million, up 53.8% from the previous year, reflecting record high annual revenue in the Company's history.- Gross Profit of $20.8 million and net income of $12.1 million, both reaching historical high, with a robust 50.3% gross margin.Financial Results for Fiscal Year Ended September 30, 2024. Gross Profit: Gross profit for the fiscal year 2024 increased by 43.2% to $20.8 million, up from $14.5 million in fiscal year 2023. Gross margin remained strong at 50.3%, reflecting effective cost control measures and a shift toward higher-m","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0345768740.USD","NVDY","SGXZ51526630.SGD","LU1923623000.USD","LU0889565833.HKD","NVD","SNVD.UK","LU1951200564.SGD","NVIW.SI","AM","IE00B5949003.HKD","LU1244550577.SGD","GMM","LU1242518857.USD","NVD3.UK","LU2125909247.SGD","LU1951198990.SGD","LU0823414551.USD","IE00BKPKM429.USD","BK4108","LU2106854487.HKD","LU1935042991.SGD","LU0823434740.USD","NVD2.UK","NVDS","IE00BHPRN162.USD","NVDA","LU0345770993.USD","EML","NVDD","LU0354030438.USD","NVDU","SG9999015952.SGD","NVDX","3NVD.UK","LU0170899867.USD","LU1429558221.USD","LU0354030511.USD","2NVD.UK","SGXZ99366536.SGD","IE00BKVL7J92.USD","LU1571399168.USD","BK4503","LU1720051108.HKD","NVDS.UK","SPA","LU0345769631.USD","LU1435385759.SGD"],"gpt_icon":1},{"id":"2501257550","title":"BCLI: Plans Coming Together for Phase 3b Trial of NurOwn® in ALS…","url":"https://stock-news.laohu8.com/highlight/detail?id=2501257550","media":"Zacks Small Cap Research","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501257550?lang=en_us&edition=fundamental","pubTime":"2025-01-06 18:05","pubTimestamp":1736157900,"startTime":"0","endTime":"0","summary":"On December 30, 2024, BrainStorm Cell Therapeutics, Inc.  conducted an investor update call to provide a corporate update. The company is currently preparing for a Phase 3b clinical trial of NurOwn in patients with amyotrophic lateral sclerosis . During 2024, the company achieved a number of significant milestones in support of the upcoming Phase 3b trial:. In April 2024, the company announced it had received written agreement from the U.S. Food and Drug Administration  under a Special Protocol Assessment  on the design of the Phase 3b trial. The SPA agreement indicates that the FDA concurs with the adequacy and acceptability of specific elements of a protocol’s overall design to ensure that the trial conducted under the protocol can be considered an adequate and well-controlled study to support marketing approval.At the final visit in the EAP, 9/10 participants were alive. A comparison of the survival curves showed","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bcli-plans-coming-together-phase-100500419.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BZ1G4Q59.USD","IE00BHPRN162.USD","LU1363072403.SGD","LU0170899867.USD","BCLI","LU0882574139.USD","BK4139","LU0267386448.USD","SPA","LU0149725797.USD","PSM","LU0971096721.USD","IE00B1BXHZ80.USD","CMC","BK4006","IE00BKVL7J92.USD"],"gpt_icon":1},{"id":"2500946401","title":"Alibaba Group Holding's Subsidiaries to Dispose Of 78.70% Stake in Sun Art","url":"https://stock-news.laohu8.com/highlight/detail?id=2500946401","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500946401?lang=en_us&edition=fundamental","pubTime":"2025-01-02 18:32","pubTimestamp":1735813921,"startTime":"0","endTime":"0","summary":"Alibaba Group Holding  subsidiaries and New Retail have entered into a Share Purchase Agreement  with Paragon Shine, involving a potential cash offer for Sun Art's entire share capital and possible delisting, according to a Wednesday filing.Alibaba holds 73.66% of Sun Art's shares through subsidiaries, A-RT Retail and Taobao China.On Dec. 31, these shares, along with an additional 5.04% from New Retail, will be sold to the purchaser under the SPA.Following the sale, the purchaser will control 78.70% of Sun Art shares. The SPA dictates a total consideration of H$11,637 million, or H$1.55 per share, subject to adjustments if the interim dividend is received beforehand.Upon SPA completion, the purchaser must make a mandatory general offer for remaining shares, including an offer to Optionholders, as per the Takeovers Code.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0261950983.USD","LU0052756011.USD","LU0880133367.SGD","LU1770034418.SGD","BK4503","SPA","LU0048580855.USD","LU0648948544.HKD","LU0605514214.HKD","BK1142","LU1242518931.SGD","LU1719994722.HKD","IE00BPRC5H50.USD","LU1282649141.HKD","LU1810669033.SGD","BK4548","BK4122","89988","LU2226246903.HKD","BABA","LU0823038988.USD","LU0501845795.SGD","BK4587","LU0229945570.USD","LU1813983027.USD","LU0797268264.HKD","LU1046422090.SGD","BK4581","LU0048597586.USD","SPA.AU","HBBD.SI","LU0823039010.USD","LU0128522744.USD","LU0828237510.HKD","LU1960683339.HKD","BK4526","LU0502904849.HKD","LU0543330483.HKD","LU0456846285.SGD","LU0823413587.USD","LU1152091168.USD","BK1591","09988","LU0348735423.USD","LU0516422440.USD","LU2097828557.USD","LU1808992512.USD","LU2039709279.SGD","LU0054450605.USD","LU1044876610.USD"],"gpt_icon":1}],"pageSize":20,"totalPage":9,"pageCount":2,"totalSize":168,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SPA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2019-02-06","symbol":"SPA","fiscalQuarterEnding":"2018/12","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1549429200000,"reportTimeType":"","actualEps":0.51},{"market":"US","date":"2018-11-08","symbol":"SPA","fiscalQuarterEnding":"2018/09","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1541653200000,"reportTimeType":"","actualEps":0.2},{"market":"US","date":"2018-09-13","symbol":"SPA","fiscalQuarterEnding":"2018/06","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1536811200000,"reportTimeType":"","actualEps":0.32},{"market":"US","date":"2018-05-09","symbol":"SPA","fiscalQuarterEnding":"2018/03","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1525838400000,"reportTimeType":"","actualEps":0.22},{"market":"US","date":"2018-02-06","symbol":"SPA","fiscalQuarterEnding":"2017/12","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1517893200000,"reportTimeType":"","actualEps":0.45}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SPA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SPA\",market:\"US\",delay:false,,,undefined,":{}}}